IL47860A - 5,9 -disubstituted 2-tetrahydrofuryl-6,7-benzomorphans andns containing them - Google Patents

5,9 -disubstituted 2-tetrahydrofuryl-6,7-benzomorphans andns containing them

Info

Publication number
IL47860A
IL47860A IL47860A IL4786075A IL47860A IL 47860 A IL47860 A IL 47860A IL 47860 A IL47860 A IL 47860A IL 4786075 A IL4786075 A IL 4786075A IL 47860 A IL47860 A IL 47860A
Authority
IL
Israel
Prior art keywords
andns
benzomorphans
tetrahydrofuryl
disubstituted
benzomorphans andns
Prior art date
Application number
IL47860A
Other languages
English (en)
Other versions
IL47860A0 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL47860A0 publication Critical patent/IL47860A0/xx
Publication of IL47860A publication Critical patent/IL47860A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL47860A 1974-08-05 1975-08-04 5,9 -disubstituted 2-tetrahydrofuryl-6,7-benzomorphans andns containing them IL47860A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IL47860A0 IL47860A0 (en) 1975-11-25
IL47860A true IL47860A (en) 1979-01-31

Family

ID=5922448

Family Applications (1)

Application Number Title Priority Date Filing Date
IL47860A IL47860A (en) 1974-08-05 1975-08-04 5,9 -disubstituted 2-tetrahydrofuryl-6,7-benzomorphans andns containing them

Country Status (27)

Country Link
US (1) US3982005A (da)
JP (1) JPS60358B2 (da)
AT (1) AT348140B (da)
BE (1) BE832099R (da)
BG (3) BG25090A3 (da)
CA (1) CA1049008A (da)
CH (7) CH613963A5 (da)
CS (1) CS189717B2 (da)
DD (1) DD122685A5 (da)
DE (1) DE2437610A1 (da)
DK (1) DK138992C (da)
ES (6) ES452766A1 (da)
FI (1) FI63229C (da)
FR (1) FR2320096A2 (da)
GB (1) GB1513950A (da)
HU (1) HU177952B (da)
IE (1) IE42216B1 (da)
IL (1) IL47860A (da)
LU (1) LU73138A1 (da)
NL (1) NL7509249A (da)
NO (1) NO143460C (da)
PH (1) PH13687A (da)
PL (3) PL99819B1 (da)
RO (3) RO67390A (da)
SE (1) SE425392B (da)
SU (3) SU591147A3 (da)
ZA (1) ZA754997B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
CL2008002199A1 (es) 2007-07-26 2009-10-23 Vitae Pharmaceuticals Inc Compuestos derivados de 1,3-oxazin-2-ona; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una enfermedad asociada con la actividad de la 11beta-hidroxiesteroide deshidrogenasa tipo 1 (11beta-hsd1) tales como dislipidemia, hiperlipidemia, hipertension, obesidad y enfermedad cardiovascular, entre otras.
AR069545A1 (es) 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の環状尿素阻害剤
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (en) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CA2723034A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
BRPI0911764A2 (pt) 2008-05-01 2015-10-06 Boehringer Ingelheim Int inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
AR071719A1 (es) 2008-05-13 2010-07-07 Boehringer Ingelheim Int Derivados aliciclicos de acido carboxilico de benzomorfanos y estructuras relacionadas, medicamentos que contienen dichos compuestos y su uso.procesos de obtencion
US8114868B2 (en) 2008-07-25 2012-02-14 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
AR078887A1 (es) * 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体
EP4253494A1 (en) 2020-11-26 2023-10-04 Shin-Etsu Chemical Co., Ltd. Room temperature curable organopolysiloxane composition, article, hydrolyzable organosilane compound and method for producing same
WO2023032745A1 (ja) 2021-09-03 2023-03-09 信越化学工業株式会社 オルガノポリシロキサン化合物、室温硬化性オルガノポリシロキサン組成物、及び物品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (da) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166804B2 (da) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
CS189717B2 (en) 1979-04-30
PL99816B1 (pl) 1978-08-31
DD122685A5 (da) 1976-10-20
ES452764A1 (es) 1977-10-16
LU73138A1 (da) 1977-04-13
RO72735A (ro) 1982-09-09
RO72736A (ro) 1982-09-09
ES452765A1 (es) 1977-10-16
GB1513950A (en) 1978-06-14
CA1049008A (en) 1979-02-20
BG25090A3 (en) 1978-07-12
NO143460B (no) 1980-11-10
NO752731L (da) 1976-02-06
SU591147A3 (ru) 1978-01-30
PL99819B1 (pl) 1978-08-31
CH613963A5 (da) 1979-10-31
FR2320096B2 (da) 1978-09-01
BE832099R (fr) 1976-02-04
FI63229B (fi) 1983-01-31
BG25089A3 (en) 1978-07-12
FR2320096A2 (fr) 1977-03-04
CH616420A5 (da) 1980-03-31
CH615678A5 (da) 1980-02-15
AU8364675A (en) 1977-02-10
CH615677A5 (da) 1980-02-15
ES452763A1 (es) 1977-10-01
SE7508789L (sv) 1976-02-10
DK352875A (da) 1976-02-06
IE42216B1 (en) 1980-07-02
PL99838B1 (pl) 1978-08-31
NO143460C (no) 1981-02-18
ES452766A1 (es) 1977-10-01
ZA754997B (en) 1977-04-27
DK138992C (da) 1979-04-30
SU587859A3 (ru) 1978-01-05
FI752211A (da) 1976-02-06
JPS5139673A (en) 1976-04-02
SU587858A3 (ru) 1978-01-05
IL47860A0 (en) 1975-11-25
BG25088A3 (en) 1978-07-12
AT348140B (de) 1979-01-25
ES452768A1 (es) 1977-10-01
IE42216L (en) 1976-02-05
JPS60358B2 (ja) 1985-01-07
SE425392B (sv) 1982-09-27
DK138992B (da) 1978-11-27
CH615679A5 (da) 1980-02-15
DE2437610A1 (de) 1976-02-26
ES452767A1 (es) 1977-10-01
CH616421A5 (da) 1980-03-31
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
US3982005A (en) 1976-09-21
CH615680A5 (da) 1980-02-15
HU177952B (en) 1982-02-28
NL7509249A (nl) 1976-02-09
FI63229C (fi) 1983-05-10
ATA523775A (de) 1978-06-15

Similar Documents

Publication Publication Date Title
IL47860A (en) 5,9 -disubstituted 2-tetrahydrofuryl-6,7-benzomorphans andns containing them
IL53485A0 (en) 2,3-dioxypiperazine derivatives
ZA751986B (en) 1,1-diaryl-1-oxadiazol-alkylamines
AU7742875A (en) New phenol-acetals
HK56980A (en) 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
AU497120B2 (en) Polyhydroxy-alkyl-3,5-disubstituted-2, 4,6-triiodo-carbanilates
IE42364L (en) Hydroxyphenylacetonitriles.
ATA392274A (de) Einrichtung zum antrieb einer durchbiegungsausgleichwalze
ZA75254B (en) 17 alpha-ethynyl (5-alpha), 2-androsten, 17 beta-ol
KE2924A (en) 2,3-dioyopiperazine derivatives
GB1487457A (en) 5,7-dihydroxy-tetraisoquinoline derivatives
IL48002A0 (en) 5-cyanoalkyl-1,3,4-thiadiazole-2-ylureas
ZA75954B (en) 1,2,4-triazolidin-3-ones
ZA756191B (en) 1,4-oxazepines
GB1516534A (en) Basically substituted 3,4-dihydro-2h-isoquinolin-1-thione
IL47507A0 (en) 2,-3-dihydroestra-1,3,5(10)-trieno-(16alpha,17alpha-beta)furan-17beta-ols
NZ178880A (en) 13-alkyl-d-jomogon-(4,16-or5(10),16)-dien-17 -ols
AU498671B2 (en) 1-aryl-2-oxo-hexahydro-2,4,5,6,7,7a-indoles
NZ177843A (en) 9-thia,-oxothia-and-dioxothia-11,12-seco-prostaglandins
IE41250B1 (en) 2,2-bis-hydroxymethylalkanesulphonates
PH11939A (en) 5,6-dibenzyloxy-2-aminotetralol derivatives
ZA751663B (en) N-substitute 1,2,4-triazoles
PH13018A (en) 1,2,4-triazolidin-2-ones
CA1029373A (en) 1,2,4-dithiaaz-3-enes
IE41730L (en) 2, 3-dihydro-1-benzothiepin-4-carboxamides